Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2694)
All Articles published online
|
Publishing Process of This Article
|
Aug 24, 2024 (publication date) through Oct 26, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Fernández C, Zafra-Martín J, Couñago F. Current challenges in the treatment of gliomas: The molecular era. World J Clin Oncol 2024; 15(8): 982-986 [PMID: 39193161 DOI: 10.5306/wjco.v15.i8.982] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Fernández C, Zafra-Martín J, Couñago F. Current challenges in the treatment of gliomas: The molecular era. World J Clin Oncol 2024; 15(8): 982-986 [PMID: 39193161 DOI: 10.5306/wjco.v15.i8.982] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v15/i8/982.htm |
| Number | Citing Articles |
| 1 |
Muhammad Hamza Shah, Sruthi Ranganathan, Nirupama Thomson, Adeleke Oluwaseun Dorcas. Precision synergy: IDH and PARP inhibitors as a dual-target strategy in IDH-mutant glioma treatment. Annals of Medicine & Surgery 2025; 87(8): 5356 doi: 10.1097/MS9.0000000000003546
|
| 2 |
Francesca Bufalieri, Daniele Armocida, Antonino Cucinotta, Pietro Familiari, Laura Di Magno, Alessandra Serraino, Gennaro Adabbo, Francesca Agnoli, Ludovica Lospinoso Severini, Manila Antonelli, Alessandro Frati, Gianluca Canettieri, Paola Infante, Antonio Santoro, Luca D'Angelo, Lucia Di Marcotullio. MEX3A is a diagnostic, independent prognostic biomarker and a promising therapeutic target in glioblastoma. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1585592
|
| 3 |
Sibtain Muhammad, Madappa C. Maridevaru, Shubham Roy, Dongxiang Chen, Wenjun Zeng, Longhu Sun, Yinghe Zhang, Bing Guo. Piezodynamic Therapy: Unleashing Mechanical Energy and Featuristic Next Generation Therapeutic Paradigms for Glioblastoma. ACS Nano 2025; 19(37): 33008 doi: 10.1021/acsnano.5c11629
|